| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $5,034,892 ) |
| | 2024 | 2024 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | D43TW010547 | Africa Center for Biostatistical Excellence: Expanding biostatistical leadership for HIV/AIDS and TB Research | 000 | 8 | NIH | 4/15/2024 | $50,000 |
| | 2024 | 2024 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | D43TW012467 | African Tuberculosis Bioinformatics Training Program | 000 | 1 | NIH | 3/19/2024 | $248,483 |
| | 2024 | 2024 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | K43TW012591 | Development of a Next-generation Rapid Phenotypic Assay for Drug-Resistant M. tuberculosis | 000 | 2 | NIH | 4/4/2024 | $106,178 |
| | 2024 | 2024 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | R01AI175235 | Identifying correlates of risk for future tuberculosis disease progression in children (INTREPID) | 001 | 2 | NIH | 3/19/2024 | $556,256 |
| | 2024 | 2024 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | R01AI175235 | Identifying correlates of risk for future tuberculosis disease progression in children (INTREPID) | 001 | 2 | NIH | 3/19/2024 | $250,000 |
| | 2024 | 2024 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | R01MH131480 | The changing face of HIV in the era of COVID-19: Maximising HIV incidence reduction through dynamic targeting of current and future distributions of acquisition risk. | 000 | 2 | NIH | 12/15/2023 | $452,894 |
| | 2024 | 2024 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | U01AI152075 | Evaluation of new diagnostics for incident, active and recurrent TB (ENDx-Tb) | 001 | 4 | NIH | 12/20/2023 | $1,350,000 |
| | 2024 | 2024 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | U01AI152075 | Evaluation of new diagnostics for incident, active and recurrent TB (ENDx-Tb) | 002 | 4 | NIH | 4/19/2024 | $150,000 |
| | 2024 | 2024 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | R01HD102050 | MECHANISMS LEADING TO ADVERSE BIRTH OUTCOMES IN SOUTH AFRICAN HIV-INFECTED WOMEN | 000 | 5 | NIH | 3/27/2024 | $173,079 |
| | 2024 | 2024 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | R01HD102050 | MECHANISMS LEADING TO ADVERSE BIRTH OUTCOMES IN SOUTH AFRICAN HIV-INFECTED WOMEN | 000 | 5 | NIH | 3/27/2024 | $119,505 |
| | 2024 | 2024 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | R01AI152109 | Nanoparticle-based host-directed therapies for eradication of Mycobacterium tuberculosis | 000 | 5 | NIH | 4/18/2024 | $111,011 |
| | 2024 | 2024 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | R01AI152109 | Nanoparticle-based host-directed therapies for eradication of Mycobacterium tuberculosis | 000 | 5 | NIH | 4/18/2024 | $192,405 |
| | 2024 | 2024 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | K43TW011006 | Interdisciplinary and multi-level approach to estimate the disease burden and outcomes of childhood tuberculous meningitis. | 000 | 5 | NIH | 12/25/2023 | $113,400 |
| | 2024 | 2024 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | D43TW010547 | Africa Center for Biostatistical Excellence: Expanding biostatistical leadership for HIV/AIDS and TB Research | 000 | 8 | NIH | 4/15/2024 | $247,464 |
| | 2024 | 2024 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | D43TW012758 | Next Generation Training in HIV Research: Immunity in the First 1000 days in mother-infant dyads (TIGRIS) | 000 | 1 | NIH | 3/28/2024 | $304,400 |
| | 2024 | 2024 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | UM1AI069521 | Stellenbosch University Clinical Trials Unit | 000 | 18 | NIH | 11/7/2023 | $657,875 |
| | 2024 | 2023 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | R33HD103093 | CHERISH (Children HIV Exposed Uninfected Research to Inform Survival and Health) | 000 | 3 | NIH | 1/26/2024 | $146,277 |
| | 2024 | 2023 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | K43TW012577 | A comprehensive whole genome sequence scan for positive selection in southern Africa | 000 | 1 | NIH | 4/18/2024 | $0 |
| | 2024 | 2023 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | K43TW012577 | A comprehensive whole genome sequence scan for positive selection in southern Africa | 000 | 1 | NIH | 4/18/2024 | $0 |
| | 2024 | 2023 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | R01AI175235 | Identifying correlates of risk for future tuberculosis disease progression in children (INTREPID) | 000 | 1 | NIH | 1/10/2024 | $0 |
| | 2024 | 2023 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | R01AI175235 | Identifying correlates of risk for future tuberculosis disease progression in children (INTREPID) | 000 | 1 | NIH | 1/10/2024 | $0 |
| | 2024 | 2023 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | U01AI152075 | Evaluation of new diagnostics for incident, active and recurrent TB (ENDx-Tb) | 000 | 3 | NIH | 12/6/2023 | $0 |
| | 2024 | 2023 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | R33HD103093 | CHERISH (Children HIV Exposed Uninfected Research to Inform Survival and Health) | 001 | 3 | NIH | 3/25/2024 | $0 |
| | 2024 | 2022 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | R01AI136836 | Inhibitors of CoA biosynthesis as novel antitubercular and antistaphylococcal agents | 000 | 5 | NIH | 2/22/2024 | $0 |
| | 2024 | 2021 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | K43TW010683 | The effect of hypertensive disorders in pregnancy and HIV-infection on maternal, birth and infant outcomes in South Africa | 000 | 5 | NIH | 3/5/2024 | -$48,058 |
| | 2024 | 2021 | STELLENBOSCH UNIVERSITY | ADMINISTRATION BUILDING B, VICTORIA ST | STELLENBOSCH | | | | ZAF | R61HD103093 | CHERISH (Children HIV Exposed Uninfected Research to Inform Survival and Health) | 000 | 2 | NIH | 1/26/2024 | -$146,277 |
|
| Issue Date FY: 2023 ( Subtotal = $8,303,833 ) (Continued on the next page) |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | K43TW011006 | Interdisciplinary and multi-level approach to estimate the disease burden and outcomes of childhood tuberculous meningitis. | 000 | 4 | NIH | 1/11/2023 | $113,400 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01HD107063 | Understanding ischemia in children with tuberculous meningitis (iThemba) | 000 | 2 | NIH | 6/1/2023 | $448,500 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | D43TW010547 | Africa Center for Biostatistical Excellence: Expanding biostatistical leadership for HIV/AIDS and TB Research | 002 | 7 | NIH | 4/21/2023 | $249,412 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | D43TW010547 | Africa Center for Biostatistical Excellence: Expanding biostatistical leadership for HIV/AIDS and TB Research | 002 | 7 | NIH | 4/21/2023 | $50,000 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R21TW012358 | Altered mitochondrial function and HIV-associatedcardiometabolic disease in populations from South Africa and Kenya (MITO-SAKen) | 001 | 2 | NIH | 6/26/2023 | $154,156 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | UM1AI069521 | Stellenbosch University Clinical Trials Unit | 001 | 17 | NIH | 6/23/2023 | $266,692 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | UM1AI069521 | Stellenbosch University Clinical Trials Unit | 001 | 17 | NIH | 6/23/2023 | $342,524 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | UM1AI069521 | Stellenbosch University Clinical Trials Unit | 000 | 17 | NIH | 12/12/2022 | $609,217 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | K43TW012591 | Development of a Next-generation Rapid Phenotypic Assay for Drug-Resistant M. tuberculosis | 000 | 1 | NIH | 7/12/2023 | $105,893 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R21TW012384 | Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke | 000 | 1 | NIH | 8/14/2023 | $165,925 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R21TW012384 | Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke | 001 | 1 | NIH | 8/16/2023 | -$165,924 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R21TW012384 | Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke | 001 | 1 | NIH | 8/16/2023 | $165,924 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01MH133488 | Harnessing male peer networks to enhance engagement with HIV prevention: A large-scale cluster randomized trial to increase HIV self-testing and PrEP uptake among men in Eastern Zimbabwe | 000 | 1 | NIH | 8/3/2023 | $500,029 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | K43TW012577 | A comprehensive whole genome sequence scan for positive selection in southern Africa | 000 | 1 | NIH | 7/21/2023 | $90,196 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | K43TW012577 | A comprehensive whole genome sequence scan for positive selection in southern Africa | 001 | 1 | NIH | 8/4/2023 | $7,207 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | K43TW012577 | A comprehensive whole genome sequence scan for positive selection in southern Africa | 002 | 1 | NIH | 8/10/2023 | -$97,402 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | K43TW012577 | A comprehensive whole genome sequence scan for positive selection in southern Africa | 002 | 1 | NIH | 8/10/2023 | $97,403 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | U01AI152075 | Evaluation of new diagnostics for incident, active and recurrent TB (ENDx-Tb) | 000 | 3 | NIH | 1/31/2023 | $1,500,000 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01AI175235 | Identifying correlates of risk for future tuberculosis disease progression in children (INTREPID) | 000 | 1 | NIH | 5/5/2023 | $590,947 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01AI175235 | Identifying correlates of risk for future tuberculosis disease progression in children (INTREPID) | 000 | 1 | NIH | 5/5/2023 | $250,000 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01AI136837 | Adaptation, fitness and resistance in rifampicin-resistant M. tuberculosis | 000 | 4 | NIH | 5/23/2023 | $136,947 |
| | 2023 | 2023 | UNIVERSITEIT STELLENBOSCH | ADMINISTRATION BUILDING B, VICTORIA STREET | STELLENBOSCH | | | | ZAF | R01MH131480 | The changing face of HIV in the era of COVID-19: Maximising HIV incidence reduction through dynamic targeting of current and future distributions of acquisition risk. | 000 | 1 | NIH | 2/16/2023 | $517,216 |
|
